Polskie Archiwum Medycyny Wewnetrznej
Tomecki R, Gerke W.
PMID: 7854963
Pol Arch Med Wewn. 1994 Oct;92(4):347-52.
No abstract available.
Cite
Tomecki R, Gerke W. Badania przesiewowe w nowotworach jelita grubego--dziś i jutro. [Screening for colorectal neoplasms--today and tomorrow]. Pol Arch Med Wewn. 1994;92(4):347-52
Tomecki, R., & Gerke, W. (1994). Badania przesiewowe w nowotworach jelita grubego--dziś i jutro. [Screening for colorectal neoplasms--today and tomorrow]. Polskie Archiwum Medycyny Wewnetrznej, 92(4), 347-52.
Tomecki, R, and Gerke, W. "Badania przesiewowe w nowotworach jelita grubego--dziś i jutro." [Screening for colorectal neoplasms--today and tomorrow]. Polskie Archiwum Medycyny Wewnetrznej vol. 92,4 (1994): 347-52.
Tomecki R, Gerke W. Badania przesiewowe w nowotworach jelita grubego--dziś i jutro. [Screening for colorectal neoplasms--today and tomorrow]. Pol Arch Med Wewn. 1994 Oct;92(4):347-52. Polish. PMID: 7854963.
Copy
Download .nbib
Methods in molecular biology (Clifton, N.J.)
Stracci F.
PMID: 19109777
Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6.
Screening should allow for the anticipation of cancer diagnosis at an earlier stage, when curative treatment is possible. Screening for cervical, large bowel, and breast cancer were shown to be effective in reducing mortality. The wide acceptance of the...
Cite
Stracci F. Cancer screenings, diagnostic technology evolution, and cancer control. Methods Mol Biol. 2009;471:107-36doi: 10.1007/978-1-59745-416-2_6.
Stracci, F. (2009). Cancer screenings, diagnostic technology evolution, and cancer control. Methods in molecular biology (Clifton, N.J.), 471107-36. https://doi.org/10.1007/978-1-59745-416-2_6
Stracci, Fabrizio. "Cancer screenings, diagnostic technology evolution, and cancer control." Methods in molecular biology (Clifton, N.J.) vol. 471 (2009): 107-36. doi: https://doi.org/10.1007/978-1-59745-416-2_6
Stracci F. Cancer screenings, diagnostic technology evolution, and cancer control. Methods Mol Biol. 2009;471:107-36. doi: 10.1007/978-1-59745-416-2_6. PMID: 19109777.
Copy
Download .nbib
Ugeskrift for laeger
Kronborg O.
PMID: 2916263
Ugeskr Laeger. 1989 Jan 23;151(4):260-3.
No abstract available.
Cite
Kronborg O. Screening for kraeft, fordele og ulemper. [Screening of cancer, advantages and disadvantages]. Ugeskr Laeger. 1989;151(4):260-3
Kronborg, O. (1989). Screening for kraeft, fordele og ulemper. [Screening of cancer, advantages and disadvantages]. Ugeskrift for laeger, 151(4), 260-3.
Kronborg, O. "Screening for kraeft, fordele og ulemper." [Screening of cancer, advantages and disadvantages]. Ugeskrift for laeger vol. 151,4 (1989): 260-3.
Kronborg O. Screening for kraeft, fordele og ulemper. [Screening of cancer, advantages and disadvantages]. Ugeskr Laeger. 1989 Jan 23;151(4):260-3. Danish. PMID: 2916263.
Copy
Download .nbib
The oncologist
McMahon PM, Gazelle SG.
PMID: 18649407
Oncologist. 2008 Jun;13(6):733. doi: 10.1634/theoncologist.2008-0116.
No abstract available.
Cite
McMahon PM, Gazelle SG. Response to "comentary: lung cancer screening--progress or peril. Oncologist. 2008;13(6):733doi: 10.1634/theoncologist.2008-0116.
McMahon, P. M., & Gazelle, S. G. (2008). Response to "comentary: lung cancer screening--progress or peril. The oncologist, 13(6), 733. https://doi.org/10.1634/theoncologist.2008-0116
McMahon, Pamela M, and Gazelle, Scott G. "Response to "comentary: lung cancer screening--progress or peril." The oncologist vol. 13,6 (2008): 733. doi: https://doi.org/10.1634/theoncologist.2008-0116
McMahon PM, Gazelle SG. Response to "comentary: lung cancer screening--progress or peril. Oncologist. 2008 Jun;13(6):733. doi: 10.1634/theoncologist.2008-0116. PMID: 18649407.
Copy
Download .nbib
Epidemiologia e prevenzione
Oleari F.
PMID: 21268768
Epidemiol Prev. 2010 Sep-Dec;34(5):3.
No abstract available.
Cite
Oleari F. Foreword. The progressive expansion of screening programmes. Epidemiol Prev. 2010;34(5):3
Oleari, F. (2010). Foreword. The progressive expansion of screening programmes. Epidemiologia e prevenzione, 34(5), 3.
Oleari, Fabrizio. "Foreword. The progressive expansion of screening programmes." Epidemiologia e prevenzione vol. 34,5 (2010): 3.
Oleari F. Foreword. The progressive expansion of screening programmes. Epidemiol Prev. 2010 Sep-Dec;34(5):3. PMID: 21268768.
Copy
Download .nbib
Canadian respiratory journal
Vozoris NT, Batt J.
PMID: 27445519
Can Respir J. 2016;2016:1850879. doi: 10.1155/2016/1850879. Epub 2016 May 30.
Purpose. There is no information on the change in prevalence of latent tuberculosis infection (LTBI) testing in the United States (US) following the introduction of the interferon gamma release assay (IGRA), a new and alternative diagnostic method for LTBI....
Cite
Vozoris NT, Batt J. Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999-2012. Can Respir J. 2016;2016:1850879doi: 10.1155/2016/1850879.
Vozoris, N. T., & Batt, J. (2016). Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999-2012. Canadian respiratory journal, 20161850879. https://doi.org/10.1155/2016/1850879
Vozoris, Nicholas T, and Batt, Jane. "Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999-2012." Canadian respiratory journal vol. 2016 (2016): 1850879. doi: https://doi.org/10.1155/2016/1850879
Vozoris NT, Batt J. Change in the Prevalence of Testing for Latent Tuberculosis Infection in the United States: 1999-2012. Can Respir J. 2016;2016:1850879. doi: 10.1155/2016/1850879. Epub 2016 May 30. PMID: 27445519; PMCID: PMC4904560.
Copy
Download .nbib
Therapeutische Umschau. Revue therapeutique
Egger M, Zwahlen M.
PMID: 23535545
Ther Umsch. 2013 Apr;70(4):193-4. doi: 10.1024/0040-5930/a000389.
No abstract available.
Cite
Egger M, Zwahlen M. Tumorscreening. [Tumor screening]. Ther Umsch. 2013;70(4):193-4doi: 10.1024/0040-5930/a000389.
Egger, M., & Zwahlen, M. (2013). Tumorscreening. [Tumor screening]. Therapeutische Umschau. Revue therapeutique, 70(4), 193-4. https://doi.org/10.1024/0040-5930/a000389
Egger, Matthias, and Zwahlen, Marcel. "Tumorscreening." [Tumor screening]. Therapeutische Umschau. Revue therapeutique vol. 70,4 (2013): 193-4. doi: https://doi.org/10.1024/0040-5930/a000389
Egger M, Zwahlen M. Tumorscreening. [Tumor screening]. Ther Umsch. 2013 Apr;70(4):193-4. doi: 10.1024/0040-5930/a000389. German. PMID: 23535545.
Copy
Download .nbib
Science (New York, N.Y.)
Kalager M, Bretthauer M.
PMID: 31919207
Science. 2020 Jan 10;367(6474):143-144. doi: 10.1126/science.aay3156.
No abstract available.
Cite
Kalager M, Bretthauer M. Improving cancer screening programs. Science. 2020;367(6474):143-144doi: 10.1126/science.aay3156.
Kalager, M., & Bretthauer, M. (2020). Improving cancer screening programs. Science (New York, N.Y.), 367(6474), 143-144. https://doi.org/10.1126/science.aay3156
Kalager, Mette, and Bretthauer, Michael. "Improving cancer screening programs." Science (New York, N.Y.) vol. 367,6474 (2020): 143-144. doi: https://doi.org/10.1126/science.aay3156
Kalager M, Bretthauer M. Improving cancer screening programs. Science. 2020 Jan 10;367(6474):143-144. doi: 10.1126/science.aay3156. PMID: 31919207.
Copy
Download .nbib
